Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children
HAART Associated Cardiotoxicity in HIV-Infected Children
Sponsor: Baylor College of Medicine
A observational or N/A phase clinical study on HIV Infections, this trial is completed. The trial is conducted by Baylor College of Medicine and has accumulated 11 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Sep 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Sep 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Aug 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Boston Children's Hospital
- Boston Medical Center
- Clinical Trials & Surveys Corp (C-TASC)
- Columbia University
- National Heart, Lung, and Blood Institute (NHLBI)
- State University of New York
- University of Illinois at Chicago
- University of Miami
- University of Puerto Rico
For direct contact, visit the study record on ClinicalTrials.gov .